| 期 |
栏目 |
标题 |
文件 |
| 卷 90, 编号 8 (2018) |
Editorial |
Russian consensus on exoand endocrine pancreatic insufficiency after surgical treatment |
(Rus)
|
| 卷 90, 编号 8 (2018) |
Editorial |
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program “odyssey” |
(Rus)
|
| 卷 90, 编号 2 (2018) |
Editorial |
Evropeyskiy registr Helicobacter pylori (Hp-EuReg): analiz dannykh 2360 bol'nykh, poluchavshikh terapiyu pervoy linii v Rossii |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018) |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
(Rus)
|
| 卷 91, 编号 4 (2019) |
Editorial |
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease |
(Rus)
|
| 卷 92, 编号 8 (2020) |
Original articles |
European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan |
(Rus)
|
| 卷 93, 编号 2 (2021) |
Reviews |
Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations) |
(Rus)
|
| 卷 94, 编号 1 (2022) |
Original articles |
Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia |
(Rus)
|
| 卷 95, 编号 2 (2023) |
Original articles |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
(Rus)
|
